CellaVision AB (CHIX:CEVIS) GF Value Rank: 8 (As of Jul. 09, 2026) — Near Median


CHIX:CEVIS CellaVision AB CHIX:CEVIS
96 GF Score
Price kr160.20
GF Value kr231.79
! 1 Warning Sign
View Full Analysis

What is CellaVision AB GF Value Rank?

CellaVision AB CHIX:CEVIS 96 GF Value Rank is 8 as of Jul. 09, 2026, which is at its 10-year median of 8.00. GuruFocus rates CHIX:CEVIS with a GF Score™ of 96/100 and a GF Value™ of kr231.79. The stock has 1 warning sign investors should review.

CellaVision AB has the GF Value Rank of 8.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

CellaVision AB GF Value Rank Related Terms

CHIX:CEVIS vs ABT, SYK, MDT: GF Value Rank Comparison

For the Medical Devices subindustry, CellaVision AB's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellaVision AB GF Value Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's GF Value Rank distribution charts can be found below:

* The bar in red indicates where CellaVision AB's GF Value Rank falls into.


CHIX:CEVIS
96GF Score
CellaVision AB CHIX:CEVIS
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 8 mean?
CellaVision AB (CHIX:CEVIS) has a GF Value Rank of 8 as of Jul. 09, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on CellaVision AB and its competitors. This is near median its historical median of 8.00. Over the past decade, CellaVision AB's GF Value Rank has ranged from 1.00 to 10.00.
Is CellaVision AB's GF Value Rank too high?
CellaVision AB's current GF Value Rank of 8 is near median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, CellaVision AB has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's GF Value Rank compare to ABT and SYK?
CellaVision AB's GF Value Rank of 8 can be compared against companies in the Medical Devices & Instruments industry. Historically, CellaVision AB's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Devices & Instruments company?
A good GF Value Rank depends on the Medical Devices & Instruments industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on CellaVision AB and its competitors. CellaVision AB's current GF Value Rank is 8, which is near median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
CellaVision AB (CHIX:CEVIS) has a current GF Value Rank of 8. The stock's GF Value™ is kr231.79, compared to a current price of kr160.20 — trading 30.9% below its estimated fair value. The current GF Value Rank is 8, which is near median its 10-year median of 8.00. CellaVision AB's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For CellaVision AB (CHIX:CEVIS), the current GF Value Rank is 8 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellaVision AB (CHIX:CEVIS) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of kr160.20 is trading 30.9% below its estimated GF Value™ of kr231.79.

Key valuation signals for CHIX:CEVIS:

  • GF Value Rank: 8 (near median its 10-year median of 8.00)
  • GF Value™: kr231.79 vs. price of kr160.20 (30.9% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the CHIX:CEVIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellaVision AB Business Description

Address Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
96GF Score

Get the complete analysis for CHIX:CEVIS

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr160.20
Price
kr231.79
GF Value